Detecting HIV transmission clusters to better prioritize prevention efforts

Size: px
Start display at page:

Download "Detecting HIV transmission clusters to better prioritize prevention efforts"

Transcription

1 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Detecting HIV transmission clusters to better prioritize prevention efforts Alexa Oster, MD Lead (Acting), Transmission and Molecular Epidemiology Team Division of HIV/AIDS Prevention, CDC May 18, 2018

2 Key points The use of molecular surveillance to identify and respond to HIV transmission clusters is a critical step toward bringing the national closer to the goal of no new infections Molecular surveillance tools can analyze HIV genetic material to help understand transmission patterns Molecular surveillance can identify transmission clusters that otherwise would go unrecognized This work offers CDC and state and local HDs the ability to implement targeted prevention activities to stop further transmission

3 Nearly 40,000 people are diagnosed with HIV each year in the U.S. Over 1 million people are living with HIV in the United States

4 Proven prevention methods are available Testing to identify previously undiagnosed infections Ensuring those with diagnosed infections are in care Providing PrEP and other prevention services Focused, community-level interventions But interventions can vary in intensity

5 How do we know where to focus the most intensive prevention efforts?

6 Targeting prevention efforts among people at risk for HIV infection More than 1 million people at risk for HIV infection in the United States Only 38,500 new infections occurred in 2015 How do we know where to focus the most intensive prevention efforts?

7 Focusing prevention efforts for people living with HIV More than 1 million people living with HIV infection in the United States Only 4 transmissions per year per 100 persons living with HIV How do we know where to focus the most intensive prevention efforts?

8 Wouldn t it be nice to have a crystal ball?

9 We don t have a crystal ball, but we do have a useful tool

10

11 So how do we identify transmission clusters and outbreaks?

12 Ways to identify transmission clusters Increases in HIV diagnoses in a geographic area or population Particularly useful in areas with low HIV prevalence Could also occur if an increase in HIV testing has diagnosed infections that are longstanding Analysis of HIV sequence data reported to HIV surveillance Particularly useful in identifying transmission clusters that are not detected through other mechanisms, those occurring in an area with a high incidence of HIV infection, those involving multiple jurisdictions HIV partner services and contact investigations Limited by completeness of elicitation of partner information Health care providers, health department staff, or community members

13 Molecular analysis to identify transmission clusters In the United States, HIV drug resistance testing is recommended for all HIV-infected persons Generates HIV nucleotide sequence data (i.e., molecular data) Molecular analysis can detect groups of people with similar HIV strains

14 Why can molecular data be used to detect transmission clusters? HIV mutates/evolves over time People living with HIV infection whose viral strains are genetically similar may be more closely related in transmission LA LA LA LA LA LA LA LA LA LA LA LA RA LA LA LA LA LA LA LA LA RA LA LA LA LA YA LA LA LA RA LA MA LA LA YA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA LA RA LA LA LA LA LA LA LA RA LA MA LA LA YA Analysis: compares nucleotide sequences to determine relatedness ACCGGATAACGGTTATCCG ACCGGATAACGGTTATCCG ACTGGATAACGGTTATCCG ACCGAATCACGGAAATCCG Adapted from presentation by J Gardy

15 Methods: Identifying transmission clusters Secure HIV-TRACE allows state and local HIV surveillance programs to conduct their own molecular analysis Identify pairs of sequences that are very closely related Connect all closely related pairs to identify clusters A B Link drawn between 2 sequences that are closely related Image courtesy of Joel Wertheim, UCSD

16 Molecular epidemiology and HIV Analysis: compares nucleotide sequences to determine relatedness A B A B Person A infected person B Person B infected person A A C B Person A infected person C, who infected person B D A B Persons D infected persons A and B We can infer a direct OR indirect epidemiologic link; we cannot infer directionality

17 Focusing on clusters that represent recent, rapid transmission Very tight genetic distance threshold Priority clusters: At least 5 persons with HIV diagnosed within the recent 12-month period But how do we know that these clusters really represent rapid transmission?

18 HIV transmission in the United States Overall: 4 transmissions per year per 100 people living with HIV

19 HIV transmission rate in priority clusters First 60 priority clusters: 44 transmissions per year per 100 persons living with HIV France AM et al. CROI 2018

20 How are nucleotide sequences collected for National HIV Surveillance System? Persons with HIV Provider orders HIV drug resistance (genotypic) testing Specimen prepared Specimen sent to laboratory Laboratory performs genotypic testing (Sanger) Genetic sequence generated and compared with reference ATGGCATCA ATGTCATCC Resistance report sent to provider Mutations identified and resistance interpreted All of these steps have to happen for a person to be part of a molecular cluster! HIV sequence reported electronically to health department State and local HDs ATGGCATCA

21 Molecular cluster Diagnosed, out of care Infected, not diagnosed At risk, not infected Link to care Test, link to care Test, consider PrEP

22 We still don t have all of the answers Planning a meeting with external partners to discuss several topics: How do we ensure that data are not used for non-public health purposes? How do we share data for public health purposes while ensuring adequate controls? What are best practices for engaging the community around this work? How do we avoid stigmatizing populations who are in need of prevention services? Many other questions remain about the optimal approaches to investigating and responding to HIV transmission clusters Evaluation of these activities will be critical to ensuring that we can determine the most effective approaches to this work

23 : Use of molecular HIV surveillance to identify active HIV transmission networks and implement HIV interventions for Hispanic/Latino MSM Three-year demonstration project (09/ /2020) co-led by PRB and HICSB Funded by Secretary s Minority AIDS Initiative Fund Four recipients: New York City, New York State, Texas, Houston Provides additional funding to grantees to implement activities that expand or enhance PS activities or increase the impact of the HIV-related activities Focuses on Hispanic/Latino MSM and persons in their networks Supports activities to mitigate the negative effects of social-structural factors on participation by these populations in high impact prevention services Supports in-depth analyses and assessments of cluster-related factors and the implementation of high impact HIV prevention services Can improve the reach and effectiveness of HIV-related services among Hispanic/Latino MSM and their network members

24 Efforts in advanced molecular detection are not limited to HIV Global Hepatitis Outbreak and Surveillance Technology (GHOST) is a web-based system that quickly shows genetic linkages between hepatitis C virus

25 Key points The use of molecular surveillance to identify and respond to HIV transmission clusters is a critical step toward bringing the national closer to the goal of no new infections Molecular surveillance tools can analyze HIV genetic material to help understand transmission patterns Molecular surveillance can identify transmission clusters that otherwise would go unrecognized This work offers CDC and state and local HDs the ability to implement targeted prevention activities to stop further transmission

26 Thank you! Alexa Oster, MD For more information, contact CDC CDC-INFO ( ) TTY: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission

Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission Alexa Oster, MD Acting Lead, Incidence

More information

Addressing HIV among Hispanic/Latino MSM

Addressing HIV among Hispanic/Latino MSM National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention Addressing HIV among Hispanic/Latino MSM Eugene McCray, M.D. Director, Division of HIV/AIDS Prevention

More information

Trends in HIV Incidence and Prevalence in the United States

Trends in HIV Incidence and Prevalence in the United States Trends in HIV Incidence and Prevalence in the United States Irene Hall, PhD, FACE 7th International Workshop on HIV Transmission Washington, DC, July 20, 2012 National Center for HIV/AIDS, Viral Hepatitis,

More information

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention Mortality Slide Series National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV Mortality Slides An analysis of trends in rates and distributions of deaths

More information

Using Partner Services Data to Enhance Molecular HIV Surveillance Cluster Analyses

Using Partner Services Data to Enhance Molecular HIV Surveillance Cluster Analyses Using Partner Services Data to Enhance Molecular HIV Surveillance Cluster Analyses Scott White, MS, MPH Epidemiology Manager Prevention, Treatment and Care Program Outline HIV in Utah Molecular HIV Surveillance

More information

High Impact Prevention: Science, Practice, and the Future of HIV

High Impact Prevention: Science, Practice, and the Future of HIV High Impact Prevention: Science, Practice, and the Future of HIV Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention

More information

State Of Tuberculosis Elimination in the United States, 2017

State Of Tuberculosis Elimination in the United States, 2017 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention State Of Tuberculosis Elimination in the United States, 2017 Philip LoBue, MD Director, Division of Tuberculosis Elimination Congressional

More information

PS : Comprehensive HIV Prevention Programs for Health Departments

PS : Comprehensive HIV Prevention Programs for Health Departments PS12-1201: Comprehensive HIV Prevention Programs for Health Departments Program Overview Erica K. Dunbar, MPH Program Leader, Health Department Initiatives National Center for HIV/AIDS, Viral Hepatitis,

More information

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Joel O. Wertheim 1,2, Alexandra M. Oster 3, Jeffrey A. Johnson 3, William M. Switzer 3, Neeraja Saduvala

More information

Sexually Transmitted Disease Prevention

Sexually Transmitted Disease Prevention Sexually Transmitted Disease Prevention April 13, 2016 Dr. Gail Bolan Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Overview of Discussion STDs:

More information

HIV Partner Services in HIV Care Programs

HIV Partner Services in HIV Care Programs Welcome HIV Partner Services in HIV Care Programs Building the Care Continuum: Comprehensive Approaches to HIV Care in California Manny Rios HIV Partner Services Specialist CDPH: Office of AIDS Brett AugsJoost

More information

Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview

Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview David W. Purcell, JD, PhD Deputy Director, Behavioral and Social Science Stephen Flores, PhD Team Lead, Prevention Research Branch

More information

Rapidly Growing Molecular Clusters of HIV in Texas. Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator

Rapidly Growing Molecular Clusters of HIV in Texas. Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator Rapidly Growing Molecular Clusters of HIV in Texas Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator Outline HIV in Texas HIV Drug Resistance testing (genotyping) in Texas Molecular

More information

Implementation of testing (and other interventions along the Continuum of Care)

Implementation of testing (and other interventions along the Continuum of Care) Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control

More information

6/2/2014. TB among Persons Experiencing Homelessness DEFINING THE PROBLEM. Overview. Sapna Bamrah Morris, MD

6/2/2014. TB among Persons Experiencing Homelessness DEFINING THE PROBLEM. Overview. Sapna Bamrah Morris, MD TB among Persons Experiencing Homelessness Sapna Bamrah Morris, MD June 11, 2014 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of TB Elimination Overview Defining the problem

More information

Looking to the Future in HIV Prevention:

Looking to the Future in HIV Prevention: Looking to the Future in HIV Prevention: A Health Department Perspective Angela C. Johnson, MPH, CHES Associate Director, Prevention ABOUT NASTAD WHO: A non-profit association founded in 1992 that represents

More information

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention Mortality Slide Series National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV Mortality Slides An analysis of trends in rates and distributions of deaths

More information

Infectious Diseases Florida Department of Health, HIV/AIDS Section/ Division of Disease Control and Health Protection Tallahassee, Florida

Infectious Diseases Florida Department of Health, HIV/AIDS Section/ Division of Disease Control and Health Protection Tallahassee, Florida Infectious Diseases Florida Department of Health, HIV/AIDS Section/ Division of Disease Control and Health Protection Tallahassee, Florida Assignment Description The Fellow will be placed in the Florida

More information

Black MSM, HIV, and the Social Determinants of Health Imperative

Black MSM, HIV, and the Social Determinants of Health Imperative Black MSM, HIV, and the Social Determinants of Health Imperative William L. Jeffries IV, PhD, MPH, MA Research Scientist June 5, 2013 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

More information

Working with Health Departments: Ingredients for Effective Collaboration Between Health Departments and CFARs. Shanell L. McGoy, Ph.D.

Working with Health Departments: Ingredients for Effective Collaboration Between Health Departments and CFARs. Shanell L. McGoy, Ph.D. Working with Health Departments: Ingredients for Effective Collaboration Between Health Departments and CFARs Shanell L. McGoy, Ph.D. MPH HIV/AIDS in the Southeast: 2 nd Annual CFAR Workshop to Address

More information

IMPLEMENTATION OF GHOST FOR HAV OUTBREAK DETECTION

IMPLEMENTATION OF GHOST FOR HAV OUTBREAK DETECTION National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention IMPLEMENTATION OF GHOST FOR HAV OUTBREAK DETECTION Sumathi Ramachandran,MS,MPH,PHD Molecular Epidemiology and Bioinformatics Team Division

More information

Bidders Conference. Amendment to Request For Proposals for Provision of HIV Prevention Services July 28, 2011

Bidders Conference. Amendment to Request For Proposals for Provision of HIV Prevention Services July 28, 2011 Chicago Department of Public Health Bidders Conference Amendment to Request For Proposals 11-03 for Provision of HIV Prevention Services July 28, 2011 Chicago Department of Public Health Division of STI/HIV

More information

Charles Boucher MD. PhD. HIV Prevention 2.0

Charles Boucher MD. PhD. HIV Prevention 2.0 Charles Boucher MD. PhD HIV Prevention 2.0 Prevention A variety of methods exists to prevent transmission of HIV Circumcision Condoms Post-exposure profylaxe (PEP) Treatment as prevention Pre-exposure

More information

Clinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States

Clinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States Clinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States Linda Beer, PhD, Christine L. Mattson, PhD, Joseph Prejean, PhD, and Luke Shouse, MD 10 th International

More information

High Impact HIV Prevention Services and Best Practices

High Impact HIV Prevention Services and Best Practices High Impact HIV Prevention Services and Best Practices David W. Purcell, JD, PhD Deputy Director for Behavioral and Social Science Division of HIV/AIDS Prevention Centers for Disease Control and Prevention

More information

Influenza Surveillance in the United St ates

Influenza Surveillance in the United St ates Influenza Surveillance in the United St ates Scot t Epperson, MPH Surveillance and Outbreak Response Team Influenza Division U.S. Centers for Disease Control and Prevention National Center for Immunization

More information

Council for Outbreak Response: Healthcare-Associated Infections & Antibiotic-Resistant Pathogens (CORHA) HICPAC December 1, 2016

Council for Outbreak Response: Healthcare-Associated Infections & Antibiotic-Resistant Pathogens (CORHA) HICPAC December 1, 2016 Council for Outbreak Response: Healthcare-Associated Infections & Antibiotic-Resistant Pathogens (CORHA) HICPAC December 1, 2016 National Center for Emerging and Zoonotic Infectious Diseases Division of

More information

Trends in U.S. HIV Diagnoses,

Trends in U.S. HIV Diagnoses, CDC FACT SHEET Trends in U.S. HIV Diagnoses, 2005-2014 More than three decades after the first cases of AIDS were diagnosed in the United States, HIV continues to pose a substantial threat to the health

More information

Stigma and HIV. Maria E. Alvarez, MPA. LEAD PUBLIC HEALTH ADVISOR Team Lead, Capacity Building Branch Partnerships Team

Stigma and HIV. Maria E. Alvarez, MPA. LEAD PUBLIC HEALTH ADVISOR Team Lead, Capacity Building Branch Partnerships Team Stigma and HIV Maria E. Alvarez, MPA LEAD PUBLIC HEALTH ADVISOR Team Lead, Capacity Building Branch Partnerships Team 3 rd Annual International Conference on Stigma Howard University Blackburn Center Washington

More information

HIV Continuum of Care Connecticut, 2015

HIV Continuum of Care Connecticut, 2015 HIV Continuum of Care Connecticut, 2015 Heidi Jenkins, Section Chief TB, HIV, STD & Viral Hepatitis Section Public Health Initiatives State of Connecticut Department of Public Health 05/25/2017 HIV Continuum

More information

HIV & HCV in TN: State of the State

HIV & HCV in TN: State of the State HIV & HCV in TN: State of the State Vanderbilt CCC HIV Symposium Nashville, TN / November 3, 2017 Carolyn Wester, MD, MPH TDH HIV/STD/VH Program Outline HIV Epidemiology Neutralizing the HIV CoC HCV Epidemiology

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

Data: Access, Sources, and Systems

Data: Access, Sources, and Systems EXEMPLARY INTEGRATED HIV PREVENTION AND CARE PLAN SECTIONS Data: Access, Sources, and Systems REGION PLAN TYPE JURISDICTIONS HIV PREVALENCE Midwest Integrated state-only prevention and care plan State

More information

The Syndemics of HIV, Hepatitis, and Overdose

The Syndemics of HIV, Hepatitis, and Overdose The Syndemics of HIV, Hepatitis, and Overdose Sara Zeigler Associate Director for Policy Office of Policy, Planning and Partnerships (proposed) Centers for Disease Control and Prevention National Center

More information

The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia

The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia Lara E. Pereira, Ph.D. Centers

More information

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection

Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,

More information

HIV/AIDS Surveillance and Reporting Requirements

HIV/AIDS Surveillance and Reporting Requirements HIV/AIDS Surveillance and Reporting Requirements New Jersey Department of Health & Senior Services Division of HIV, STD, TB Services Princeton, NJ March 21, 2012 1 Introduction Review HIV Reporting Requirements

More information

Stepwise Process for Improving the Quality of HIV-related POCT Sites Towards Certification

Stepwise Process for Improving the Quality of HIV-related POCT Sites Towards Certification Implementing Quality-Assured Point-of-Care Testing Stepwise Process for Improving the Quality of HIV-related POCT Sites Towards Certification Center for Global Health Division of Global HIV and TB*- International

More information

CDC s Response to the Viral Hepatitis/Opioid Syndemic

CDC s Response to the Viral Hepatitis/Opioid Syndemic National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Viral Hepatitis CDC s Response to the Viral Hepatitis/Opioid Syndemic A Blythe Ryerson, PhD, MPH Associate Director for

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

Trends in Testing for Mycobacterium tuberculosis Complex from US Public Health Laboratories,

Trends in Testing for Mycobacterium tuberculosis Complex from US Public Health Laboratories, Trends in Testing for Mycobacterium tuberculosis Complex from US Public Health Laboratories, 2009 2013 Frances Tyrrell, MT (ASCP), MPH Laboratory Consultant Laboratory Capacity Team (LCT)/DTBE ftyrrell@cdc.gov

More information

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [60Day-12-12MW]

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [60Day-12-12MW] Billing Code: 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-12-12MW] Proposed Data Collections Submitted for Public Comment and Recommendations In

More information

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Getting to Zero in California: Integration of HIV Prevention and Surveillance Getting to Zero in California: Integration of HIV Prevention and Surveillance Steve Gibson, MSW and Deanna Sykes, PhD CDPH, Office of AIDS November 27, 2017 Learning Objectives Understand reasons for integrated

More information

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States

More information

MHS Molecular HIV Surveillance(?) and Community Engagement. David Evans, Director of HIV Programs Dana Van Gorder, Executive Director

MHS Molecular HIV Surveillance(?) and Community Engagement. David Evans, Director of HIV Programs Dana Van Gorder, Executive Director MHS Molecular HIV Surveillance(?) and Community Engagement David Evans, Director of HIV Programs Dana Van Gorder, Executive Director Community Consultation and Data 2 Care The Environment in 2012 Few community

More information

STD Partner Services for MSM Can Be Used to Promote PrEP and Identify People Living with HIV Who are Inadequately Engaged in Care

STD Partner Services for MSM Can Be Used to Promote PrEP and Identify People Living with HIV Who are Inadequately Engaged in Care STD Partner Services for MSM Can Be Used to Promote PrEP and Identify People Living with HIV Who are Inadequately Engaged in Care David A. Katz, Julia C. Dombrowski, Dawn Spellman, Teal R. Bell, Matthew

More information

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention New Generation of Nucleic Acid Testing Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention Percentage (%) Persons Living with Diagnosed or Undiagnosed HIV Infection

More information

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Surveillance in Urban and Nonurban Areas National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Infection in Urban and Nonurban Areas Many ways to characterize

More information

Strengthening Linkages: why & how to connect our dots

Strengthening Linkages: why & how to connect our dots Strengthening Linkages: why & how to connect our dots Sophy S. Wong, MD Medical Director, Bay Area & North Coast AETC Associate Clinical Professor of Medicine, UCSF Workshop objectives Why linkage matters

More information

Challenges in Communicating to Baby Boomers about Hepatitis C: Lessons Learned from the Know More Hepatitis Campaign

Challenges in Communicating to Baby Boomers about Hepatitis C: Lessons Learned from the Know More Hepatitis Campaign National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Viral Hepatitis Challenges in Communicating to Baby Boomers about Hepatitis C: Lessons Learned from the Know More Hepatitis

More information

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ]

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ] This document is scheduled to be published in the Federal Register on 06/18/2018 and available online at https://federalregister.gov/d/2018-12971, and on FDsys.gov Billing Code: 4163-18-P DEPARTMENT OF

More information

Looking at NY: Our rate of chlamydia is higher than the US as a whole; we rank 13th among all states.

Looking at NY: Our rate of chlamydia is higher than the US as a whole; we rank 13th among all states. 1 In this presentation, we will discuss: What are the most common STDs in NYS What are the most common STDs Can I get gonorrhea from oral sex How do you know if you/or your partner has an STD? Does getting

More information

Illustrating HIV/AIDS in the United States Update

Illustrating HIV/AIDS in the United States Update Illustrating HIV/AIDS in the United States 2016 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S. alongside critical

More information

Update: ACIP Recommendations for Hepatitis B Vaccination

Update: ACIP Recommendations for Hepatitis B Vaccination National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Update: ACIP Recommendations for Hepatitis B Vaccination Sarah Schillie, MD, MPH, MBA Summit for the Elimination of Hepatitis B and

More information

Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States

Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States Harrell Chesson Health Economist Centers for Disease Control and Prevention National Coalition of STD Directors

More information

Improving HIV Prevention and Care in New Mexico Through Integrated Planning

Improving HIV Prevention and Care in New Mexico Through Integrated Planning Improving HIV Prevention and Care in New Mexico Through Integrated Planning Andrew Gans, MPH HIV, STD and Hepatitis Section Manager National Goals 1 Goals in the National HIV/AIDS Strategy (NHAS) 1. Reduce

More information

C-YA! Philadelphia s Plan to Connect our Co-infected Community to a Cure for Hep C ALEX SHIRREFFS, MPH NASTAD TA MEETING NOVEMBER 29, 2017

C-YA! Philadelphia s Plan to Connect our Co-infected Community to a Cure for Hep C ALEX SHIRREFFS, MPH NASTAD TA MEETING NOVEMBER 29, 2017 C-YA! Philadelphia s Plan to Connect our Co-infected Community to a Cure for Hep C ALEX SHIRREFFS, MPH NASTAD TA MEETING NOVEMBER 29, 2017 Agenda: Background C YA Project Activities Data and Evaluation

More information

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center

More information

Missouri Statewide Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need, CY

Missouri Statewide Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need, CY Missouri Statewide Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need, CY 2017-2021 September 20, 2016 Developed through the collaborative efforts of the following

More information

HIV Planning: From Guidance to Implementation. Joan Llanes Assistant Program Manager Division of Community Advancement and Leadership Strategies

HIV Planning: From Guidance to Implementation. Joan Llanes Assistant Program Manager Division of Community Advancement and Leadership Strategies HIV Planning: From Guidance to Implementation Joan Llanes Assistant Program Manager Division of Community Advancement and Leadership Strategies Overview HIV Planning Guidance Implementing HIV Planning

More information

Planning for Action at the Local Level

Planning for Action at the Local Level Planning for Action at the Local Level Webcast 2.1 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department Communicable Disease Control Program Manager Webcast Overview 1 Developments

More information

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral

More information

California s Experiences Using Tuberculosis Whole Genome Sequencing

California s Experiences Using Tuberculosis Whole Genome Sequencing California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section

More information

HIV Drug Resistance (HIVDR)

HIV Drug Resistance (HIVDR) Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,

More information

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Director, Program for Viral Hepatitis Elimination, Task Force for Global Health Senior Scientist, National Center for HIV/AIDS,

More information

The State of Asthma. Jeanne Moorman, NCEH Survey Statistician National Asthma Program

The State of Asthma. Jeanne Moorman, NCEH Survey Statistician National Asthma Program The State of Asthma American College of Chest Physicians 14th Annual ACCP Community Asthma and COPD Coalitions Symposium October 24-25, 212 Atlanta, GA Jeanne Moorman, NCEH Survey Statistician National

More information

Impact of ART resistance in sub Saharan Africa

Impact of ART resistance in sub Saharan Africa Impact of ART resistance in sub Saharan Africa Elliot Raizes, MD Division of Global HIV/TB US Centers for Disease Control and Prevention ITREMA Resistance Training Workshop 24 October, 2018 Center for

More information

STD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018

STD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018 Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018 MISSION Improve health outcomes in communities disproportionately impacted by HIV and STDs Collect, study and publish data Diagnose and

More information

Ability to Identify Acute HIV Infections from Surveillance Data Varies by Diagnostic Testing Algorithm

Ability to Identify Acute HIV Infections from Surveillance Data Varies by Diagnostic Testing Algorithm Ability to Identify Acute HIV Infections from Surveillance Data Varies by Diagnostic Testing Algorithm Laurie Linley, MPH; Anne H. Peruski, MPH, PhD; Richard M. Selik, MD; Kevin P. Delaney, MPH, PhD; Alexandra

More information

Technical guidance for Round 9 Global Fund HIV proposals

Technical guidance for Round 9 Global Fund HIV proposals Technical guidance for Round 9 Global Fund HIV proposals Broad Area Service Delivery Area TREATMENT Prevention and assessment of HIV drug resistance (HIVDR) This technical brief provides key information

More information

One Health Zoonotic Disease Prioritization

One Health Zoonotic Disease Prioritization Centers for Disease Control and Prevention One Health Zoonotic Disease Prioritization Casey Barton Behravesh DVM, DrPH Director, CDC One Health Office National Center for Emerging and Zoonotic Infectious

More information

The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective

The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective National Center for Immunization & Respiratory Diseases The Perinatal Hepatitis B Prevention Program (PHBPP): The National Perspective Nancy Fenlon, RN, MS Perinatal Hepatitis B Prevention Program Coordinator,

More information

USG Policy Perspectives on Global Influenza

USG Policy Perspectives on Global Influenza USG Policy Perspectives on Global Influenza IOM Committee for the Assessment of DoD-GEIS Influenza Surveillance & Response Programs Ms. Ellen P. Embrey Deputy Assistant Secretary of Defense Force Health

More information

Hepatitis A and B outbreaks in Massachusetts,

Hepatitis A and B outbreaks in Massachusetts, Hepatitis A and B outbreaks in Massachusetts, 2017-2018 Shauna Onofrey, MPH Viral Hepatitis Surveillance Coordinator Massachusetts Department of Public Health Massachusetts Background Population: 6.86

More information

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami 1 1 Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami 3 Defining the End of AIDS Reduce new infections to 750 annually by the end of 2020 Three Point Plan 1. Identify all persons

More information

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and

More information

Prevention and control of hepatitis B and C in the European Region of WHO

Prevention and control of hepatitis B and C in the European Region of WHO Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region

More information

Receptive Anal Intercourse and HIV Infection

Receptive Anal Intercourse and HIV Infection World Journal of AIDS, 2017, 7, 269-278 http://www.scirp.org/journal/wja ISSN Online: 2160-8822 ISSN Print: 2160-8814 Receptive Anal Intercourse and HIV Infection Gilbert R. Lavoie 1, John F. Fisher 2

More information

San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment

San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment Background and Purpose San Francisco Department of Public Health This syndemics assessment is the first step in developing a sustainable system of primary prevention and clinical care in San Francisco

More information

California s Experiences Using Tuberculosis Whole Genome Sequencing

California s Experiences Using Tuberculosis Whole Genome Sequencing California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section

More information

Program Collaboration and Service Integration

Program Collaboration and Service Integration Program Collaboration and Service Integration One Size Does Not Fit All Amanuel Rosario, MD Medical Director, TB Control District of Columbia Department of Health Marcelo Fernandez-Viña, MPH Adult Viral

More information

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections

More information

HIV in the United Kingdom

HIV in the United Kingdom HIV in the United Kingdom Valerie Delpech and Alison Brown on behalf of the HIV and AIDS Reporting Section National Infection Service Public Health England Released 15 December 2017 Undetectable=Untransmittable

More information

National HIV/AIDS Strategy

National HIV/AIDS Strategy National HIV/AIDS Strategy WHERE CAN YOU FIT INTO THIS? ANNA KINDER, M.S.OTR/L Definition THE NATIONAL HIV/AIDS STRATEGY IS A FIVE-YEAR PLAN THAT DETAILS PRINCIPLES, PRIORITIES, AND ACTIONS TO GUIDE OUR

More information

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Zero HIV infections Zero HIV deaths Zero HIV stigma Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Number of New HIV Diagnoses Overall decline in new HIV diagnoses and death in San

More information

MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations

MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations CDC HIV/AIDS Fa c t s S e p t e m b e r 2008 On August 6, 2008, the Centers for Disease Control and Prevention (CDC) released a new

More information

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

More information

CDC Programmatic Activities in Breast and Ovarian Cancer Genomics

CDC Programmatic Activities in Breast and Ovarian Cancer Genomics CDC Programmatic Activities in Breast and Ovarian Cancer Genomics Katrina F. Trivers, PhD, MSPH Epidemiologist Division of Cancer Prevention and Control CDC The First Line of Defense: Application of Breast

More information

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan STD & HIV ANNUAL REPORT 2016 An Annual Review of HIV and STD s reported in Oakland County, Michigan Similar to numbers reported statewide, Oakland County saw an increase in the number of reported cases

More information

2009 H1N1 flu. H1N1 update US. H1N1 update US

2009 H1N1 flu. H1N1 update US. H1N1 update US 2009 H1N1 flu Ned Calonge, MD, MPH Chief Medical Officer Colorado Department of Public Health and Environment H1N1 update US US: 593 deaths reported 9,079 hospitalizations in US since spring CDC has officially

More information

RE-LINKAGE TO CARE OF HIV AND HEPATITIS C CO-INFECTED PATIENTS IN NEW YORK CITY

RE-LINKAGE TO CARE OF HIV AND HEPATITIS C CO-INFECTED PATIENTS IN NEW YORK CITY RE-LINKAGE TO CARE OF HIV AND HEPATITIS C CO-INFECTED PATIENTS IN NEW YORK CITY HIV EPIDEMIOLOGY AND FIELD SERVICES PROGRAM FIELD SERVICES UNIT NANCY KUZMYAK AND TANZILA PERVIN, PUBLIC HEALTH ADVISORS

More information

All four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding.

All four components must be present, but Part A funds to be used for HIV testing only as necessary to supplement, not supplant, existing funding. EARLY INTERVENTION SERVICES I. DEFINITION OF SERVICE Support of Early Intervention Services (EIS) that include identification of individuals at points of entry and access to services and provision of:

More information

State of Iowa IDPH. Hepatitis C Virus. Iowa Department of Public Health. End-of-Year Surveillance Report

State of Iowa IDPH. Hepatitis C Virus. Iowa Department of Public Health. End-of-Year Surveillance Report State of Iowa Hepatitis C Virus End-of-Year 2016 Surveillance Report IDPH Iowa Department of Public Health Hepatitis C Virus (HCV) End-of-Year Surveillance Report: 2016 Table of Contents Executive Summary...

More information

Partner Services: Opportunities for Integration and Innovation

Partner Services: Opportunities for Integration and Innovation Partner Services: Opportunities for Integration and Innovation Jessica Frasure Williams, MPH Director of Programs and Partnerships National Coalition of STD Directors (NCSD) EMERGING FUNCTIONS OF PARTNER

More information

Curing Hepatitis C in the Ryan White HIV/AIDS Program

Curing Hepatitis C in the Ryan White HIV/AIDS Program Curing Hepatitis C in the Ryan White HIV/AIDS Program Laura Cheever, MD, ScM Associate Administrator HIV/AIDS Bureau (HAB) Health Resources and Services Administration (HRSA) Health Resources and Services

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) Written Testimony for the Record to the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY 2018 Appropriations for HIV/AIDS Programs Submitted by Dr. Wendy

More information

Digital Adherence Interventions: A Review of CDC Investments in IT-Based Technologies

Digital Adherence Interventions: A Review of CDC Investments in IT-Based Technologies Digital Adherence Interventions: A Review of CDC Investments in IT-Based Technologies Linda J. Koenig, PhD Chief, Prevention Research Branch Division of HIV/AIDS Prevention, CDC Kathleen D. Green, PhD

More information

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014 Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations Emily McCloskey USCA October 3, 2014 About NASTAD NASTAD is an international non-profit association of U.S. state

More information